Amrutanjan Health Care Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Net profit of Amrutanjan Health Care rose 6.65% to Rs 16.19 crore in the quarter ended March 2026 as against Rs 15.18 crore during the previous quarter ended March 2025. Sales rose 10.60% to Rs 149.77 crore in the quarter ended March 2026 as against Rs 135.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.95% to Rs 57.92 crore in the year ended March 2026 as against Rs 50.83 crore during the previous year ended March 2025. Sales rose 11.23% to Rs 502.55 crore in the year ended March 2026 as against Rs 451.82 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting held on 08 May 2026, has recommended a Final Dividend of Rs.2.90 per share (i.e.290%), subject to the approval of the shareholders.

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 8 May 2026.

Net profit of Amrutanjan Health Care rose 1.04% to Rs 19.45 crore in the quarter ended December 2025 as against Rs 19.25 crore during the previous quarter ended December 2024. Sales rose 14.90% to Rs 141.04 crore in the quarter ended December 2025 as against Rs 122.75 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News